250 related articles for article (PubMed ID: 21671028)
1. Novel developments in thrombotic microangiopathies: is there a common link between hemolytic uremic syndrome and thrombotic thrombocytic purpura?
Zipfel PF; Wolf G; John U; Kentouche K; Skerka C
Pediatr Nephrol; 2011 Nov; 26(11):1947-56. PubMed ID: 21671028
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
Polito MG; Kirsztajn GM
J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
[TBL] [Abstract][Full Text] [Related]
3. Thrombotic microangiopathies: new insights and new challenges.
Zipfel PF; Heinen S; Skerka C
Curr Opin Nephrol Hypertens; 2010 Jul; 19(4):372-8. PubMed ID: 20539230
[TBL] [Abstract][Full Text] [Related]
4. Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS).
Licht C; Stapenhorst L; Simon T; Budde U; Schneppenheim R; Hoppe B
Kidney Int; 2004 Sep; 66(3):955-8. PubMed ID: 15327386
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune forms of thrombotic microangiopathy and membranoproliferative glomerulonephritis: Indications for a disease spectrum and common pathogenic principles.
Skerka C; Licht C; Mengel M; Uzonyi B; Strobel S; Zipfel PF; Józsi M
Mol Immunol; 2009 Sep; 46(14):2801-7. PubMed ID: 19640589
[TBL] [Abstract][Full Text] [Related]
6. [Pathophysiology of thrombotic microangiopathies: current understanding].
Coppo P; Veyradier A; Durey MA; Fremeaux-Bacchi V; Scrobohaci ML; Amesland F; Bussel A
Ann Med Interne (Paris); 2002 May; 153(3):153-66. PubMed ID: 12218898
[TBL] [Abstract][Full Text] [Related]
7. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
Furlan M; Lämmle B
Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
[TBL] [Abstract][Full Text] [Related]
8. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
Moake JL; McPherson PD
Am J Med; 1989 Sep; 87(3N):9N-15N. PubMed ID: 2486537
[TBL] [Abstract][Full Text] [Related]
9. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.
Mannucci PM; Cugno M
Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489
[TBL] [Abstract][Full Text] [Related]
10. [Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura].
Masset C; Dubois B; Rorive G
Rev Med Liege; 2002 Jan; 57(1):33-9. PubMed ID: 11899496
[TBL] [Abstract][Full Text] [Related]
11. [Thrombotic microangiopathies: thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS). Morphological features, differential diagnosis, and pathogenesis].
Honsová E
Cesk Patol; 2008 Jul; 44(3):54-8. PubMed ID: 18783134
[TBL] [Abstract][Full Text] [Related]
12. Unrecognized pattern of von Willebrand factor abnormalities in hemolytic uremic syndrome and thrombotic thrombocytopenic purpura.
Galbusera M; Benigni A; Paris S; Ruggenenti P; Zoja C; Rossi C; Remuzzi G
J Am Soc Nephrol; 1999 Jun; 10(6):1234-41. PubMed ID: 10361861
[TBL] [Abstract][Full Text] [Related]
13. Thrombotic microangiopathies: towards a pathophysiology-based classification.
Coppo P; Veyradier A
Cardiovasc Hematol Disord Drug Targets; 2009 Mar; 9(1):36-50. PubMed ID: 19275576
[TBL] [Abstract][Full Text] [Related]
14. Increased fragmentation of von Willebrand factor, due to abnormal cleavage of the subunit, parallels disease activity in recurrent hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and discloses predisposition in families. The Italian Registry of Familial and Recurrent HUS/TTP.
Galbusera M; Noris M; Rossi C; Orisio S; Caprioli J; Ruggeri ZM; Amadei B; Ruggenenti P; Vasile B; Casari G; Remuzzi G
Blood; 1999 Jul; 94(2):610-20. PubMed ID: 10397728
[TBL] [Abstract][Full Text] [Related]
15. Thrombotic microangiopathies: from animal models to human disease and cure.
Caprioli J; Remuzzi G; Noris M
Contrib Nephrol; 2011; 169():337-350. PubMed ID: 21252531
[TBL] [Abstract][Full Text] [Related]
16. [Hemolytic and uremic syndrome and related thrombotic microangiopathies: Epidemiology, pathophysiology and clinics].
Rafat C; Coppo P; Fakhouri F; Frémeaux-Bacchi V; Loirat C; Zuber J; Rondeau E
Rev Med Interne; 2017 Dec; 38(12):817-824. PubMed ID: 28711159
[TBL] [Abstract][Full Text] [Related]
17. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: pathophysiology and management.
Myers L
Nephrol Nurs J; 2002 Apr; 29(2):171-80; quiz 181-2. PubMed ID: 11997952
[TBL] [Abstract][Full Text] [Related]
18. Thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy.
Byrnes JJ; Moake JL
Clin Haematol; 1986 May; 15(2):413-42. PubMed ID: 3524932
[TBL] [Abstract][Full Text] [Related]
19. [Thrombotic microangiopathies: HUS/TTP. Physiopathological aspects].
Sánchez Avalos JC
Medicina (B Aires); 2000; 60(1):46-58. PubMed ID: 10835700
[TBL] [Abstract][Full Text] [Related]
20. Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome.
Moake JL
Arch Pathol Lab Med; 2002 Nov; 126(11):1430-3. PubMed ID: 12421153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
